Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnosis
|
| gptkbp:approvedBy |
gptkb:FDA
leukemia multiple myeloma chronic lymphocytic leukemia |
| gptkbp:detects |
B-cell receptor sequences
T-cell receptor sequences |
| gptkbp:developedBy |
gptkb:Adaptive_Biotechnologies
|
| https://www.w3.org/2000/01/rdf-schema#label |
clonoSEQ
|
| gptkbp:launched |
2017
|
| gptkbp:marketedAs |
gptkb:Adaptive_Biotechnologies
|
| gptkbp:measures |
clonality of immune cells
|
| gptkbp:regulates |
FDA-cleared
|
| gptkbp:technology |
next-generation sequencing
|
| gptkbp:type |
blood
bone marrow |
| gptkbp:usedFor |
minimal residual disease detection
lymphoid malignancies |
| gptkbp:website |
https://www.clonoseq.com/
|
| gptkbp:bfsParent |
gptkb:Adaptive_Biotechnologies
|
| gptkbp:bfsLayer |
7
|